Immune Therapeutics Inc. appointed Jack Brewer as a board member.
Brewer is the CEO and founder of the Brewer Group Cos. He manages Brewer's private portfolio, which focuses on impact investing.
Immune Therapeutics said that Brewer has assisted in the company's expansion into international markets, such as Malawi and Haiti, and has recently started work to help the company expand registration into India.
Orlando, Fla.-based Immune Therapeutics develops immunotherapies for autoimmune and inflammatory diseases, cancer, HIV/AIDS and animal diseases.